REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 43 filers reported holding REDHILL BIOPHARMA LTD in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,015 | -77.6% | 14,364 | +33.4% | 0.00% | – |
Q2 2022 | $9,000 | -90.9% | 10,770 | -72.4% | 0.00% | – |
Q1 2022 | $99,000 | -56.8% | 39,075 | -56.7% | 0.00% | – |
Q4 2021 | $229,000 | -78.1% | 90,276 | -60.5% | 0.00% | – |
Q3 2021 | $1,044,000 | +635.2% | 228,399 | +1002.0% | 0.00% | – |
Q2 2021 | $142,000 | +49.5% | 20,725 | +59.4% | 0.00% | – |
Q1 2021 | $95,000 | 0.0% | 13,000 | -38.2% | 0.00% | – |
Q1 2020 | $95,000 | -75.3% | 21,036 | -64.6% | 0.00% | -100.0% |
Q2 2019 | $384,000 | +39.1% | 59,405 | +108.1% | 0.00% | 0.0% |
Q1 2017 | $276,000 | – | 28,548 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GAGNON SECURITIES LLC | 367,346 | $926,000 | 0.15% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,950,002 | $4,914,000 | 0.11% |
Claret Asset Management Corp | 95,430 | $240,000 | 0.05% |
Annandale Capital, LLC | 43,532 | $110,000 | 0.04% |
ARK Investment Management | 861,798 | $2,172,000 | 0.01% |
Virtu Financial LLC | 26,864 | $68,000 | 0.01% |
Ancora Advisors LLC | 82,048 | $207,000 | 0.01% |
OSAIC HOLDINGS, INC. | 4,600 | $1,372,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 25,499 | $64,000 | 0.00% |
ATTICUS WEALTH MANAGEMENT, LLC | 2,425 | $6,000 | 0.00% |